SITEMAP
- ]HOME
- ]WHO WE ARE
- WAbout Sutro
- WLeadership
- [Leadership Team
- [Functional Leadership Team
- [Board of Directors
- [Scientific Advisory Board
- [Clinical Advisory Board
- WCollaborations
- WCorporate Presentation
- ]CLINICAL TRIALS & PATIENTS
- WClinical Trials
- WREFRαME
- [REFRαME-L1 Patients
- [REFRαME-O1 Patients
- ^REFRαME-O1 Clinical Trial Overview
- [REFRαME-P1 Patients
- ]PATIENTS
- WPatient Resources
- WCommitment To Patients
- WCompassionate Use Access
- ]SCIENCE
- WPipeline
- WiADCs & Antibody-Drug Conjugates
- WXpressCF+®
- WcGMP Facility
- ]INVESTORS
- WOverview
- WNews & Events
- [Overview
- [News Releases
- [Events & Audio Replays
- [Email Alerts
- WCompany Info
- [Overview
- [Management Team
- [Functional Leadership Team
- [Presentations
- [Contacts
- [FAQ
- WFinancial Info
- [Overview
- [Financial Results
- [Income Statement
- [Balance Sheet
- [Cash Flow
- WStock Data
- [Quote
- [Charts
- [Historical Data
- [Analysts Coverage
- WSEC Filings
- [Overview
- [All SEC Filings
- [Annual Reports
- [Quarterly Reports
- [Section 16 Filings
- WGovernance
- [Overview
- [Board of Directors
- [Board Committees
- [Governance Documents
- ]NEWS
- WNews Releases
- WPresentation & Publication
- WEvents
- WEvents Audio Replays
- ]JOIN US
- WThe Way We Work
- WJoin Our Team
- WDEIB
- WSustainability
- WInternships
- WPhilanthropy
- [Employee Engagement
- ]CONTACT US